Exome Asset Management LLC Quant / Systematic

Location: New York, NY

CIK: 0002011932 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $162M (100.0% shares, 0.0% debt)

Holdings (52)

GH GUARDANT HEALTH INC 6.2%
Value $10.13M Shares 67,500 Est. Cost Unrealized
PRAX PRAXIS PRECISION MEDICINES I 5.6%
Value $9.108M Shares 27,205 Est. Cost Unrealized
TGTX TG THERAPEUTICS INC 5.6%
Value $9.06M Shares 164,915 Est. Cost Unrealized
COGT COGENT BIOSCIENCES INC 5.0%
Value $8.147M Shares 210,523 Est. Cost Unrealized
IONS IONIS PHARMACEUTICALS INC 4.3%
Value $6.992M Shares 88,177 Est. Cost Unrealized
LLY ELI LILLY & CO 4.1%
Value $6.587M Shares 5,492 Est. Cost Unrealized
ABVX ABIVAX SA 3.9%
Value $6.247M Shares 46,878 Est. Cost Unrealized
ALMS ALUMIS INC 3.5%
Value $5.752M Shares 204,418 Est. Cost Unrealized
CYTK CYTOKINETICS INC 3.2%
Value $5.116M Shares 60,056 Est. Cost Unrealized
ELVN ENLIVEN THERAPEUTICS INC 3.1%
Value $5.085M Shares 100,203 Est. Cost Unrealized
VERA VERA THERAPEUTICS INC 2.6%
Value $4.174M Shares 97,276 Est. Cost Unrealized
UNH UNITEDHEALTH GROUP INC 2.5%
Value $3.995M Shares 9,612 Est. Cost Unrealized
TXG 10X GENOMICS INC 2.4%
Value $3.935M Shares 102,629 Est. Cost Unrealized
NTRA NATERA INC 2.3%
Value $3.746M Shares 13,800 Est. Cost Unrealized
QURE UNIQURE NV 2.3%
Value $3.733M Shares 81,056 Est. Cost Unrealized
RYTM RHYTHM PHARMACEUTICALS INC 2.2%
Value $3.576M Shares 32,209 Est. Cost Unrealized
MAZE MAZE THERAPEUTICS INC 2.1%
Value $3.422M Shares 114,692 Est. Cost Unrealized
GLUE MONTE ROSA THERAPEUTICS INC 2.0%
Value $3.318M Shares 137,115 Est. Cost Unrealized
MLTX MOONLAKE IMMUNOTHERAPEUTICS 2.0%
Value $3.242M Shares 166,493 Est. Cost Unrealized
ALKS ALKERMES PLC 2.0%
Value $3.214M Shares 61,336 Est. Cost Unrealized
LQDA LIQUIDIA CORPORATION 1.9%
Value $3.127M Shares 39,224 Est. Cost Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 1.8%
Value $2.931M Shares 5,410 Est. Cost Unrealized
GKOS GLAUKOS CORP 1.7%
Value $2.776M Shares 19,862 Est. Cost Unrealized
ARWR ARROWHEAD PHARMACEUTICALS IN 1.6%
Value $2.626M Shares 32,214 Est. Cost Unrealized
AGIO AGIOS PHARMACEUTICALS INC 1.6%
Value $2.616M Shares 70,500 Est. Cost Unrealized
CBIO CRESCENT BIOPHARMA INC. 1.4%
Value $2.3M Shares 127,769 Est. Cost Unrealized
AZN ASTRAZENECA PLC 1.4%
Value $2.254M Shares 12,045 Est. Cost Unrealized
BSX BOSTON SCIENTIFIC CORP 1.3%
Value $2.063M Shares 48,347 Est. Cost Unrealized
ADAG ADAGENE INC 1.3%
Value $2.051M Shares 488,293 Est. Cost Unrealized
PEN PENUMBRA INC 1.2%
Value $1.989M Shares 6,300 Est. Cost Unrealized
ISRG INTUITIVE SURGICAL INC 1.2%
Value $1.952M Shares 4,908 Est. Cost Unrealized
VKTX VIKING THERAPEUTICS INC 1.2%
Value $1.867M Shares 47,861 Est. Cost Unrealized
OCUL OCULAR THERAPEUTIX INC 1.1%
Value $1.783M Shares 181,588 Est. Cost Unrealized
EQ EQUILLIUM INC 1.1%
Value $1.769M Shares 552,956 Est. Cost Unrealized
ASND ASCENDIS PHARMA A/S 1.1%
Value $1.753M Shares 6,573 Est. Cost Unrealized
CRBP CORBUS PHARMACEUTICALS HLDGS 1.1%
Value $1.734M Shares 184,914 Est. Cost Unrealized
CTMX CYTOMX THERAPEUTICS INC. 1.1%
Value $1.725M Shares 460,067 Est. Cost Unrealized
VSTM VERASTEM INC 1.0%
Value $1.639M Shares 429,041 Est. Cost Unrealized
NKTR NEKTAR THERAPEUTICS 1.0%
Value $1.565M Shares 22,417 Est. Cost Unrealized
CLPT CLEARPOINT NEURO INC 0.9%
Value $1.492M Shares 83,636 Est. Cost Unrealized
INSM INSMED INC 0.9%
Value $1.479M Shares 13,873 Est. Cost Unrealized
CAI CARIS LIFE SCIENCES INC 0.9%
Value $1.393M Shares 78,180 Est. Cost Unrealized
BBIO BRIDGEBIO PHARMA INC 0.8%
Value $1.367M Shares 18,359 Est. Cost Unrealized
ZBIO ZENAS BIOPHARMA INC 0.8%
Value $1.331M Shares 52,443 Est. Cost Unrealized
NBP NOVABRIDGE BIOSCIENCES 0.7%
Value $1.125M Shares 576,960 Est. Cost Unrealized
ESTA ESTABLISHMENT LABS HLDGS INC 0.7%
Value $1.124M Shares 13,100 Est. Cost Unrealized
RLAY RELAY THERAPEUTICS INC 0.5%
Value $889K Shares 47,531 Est. Cost Unrealized
GERN GERON CORP 0.5%
Value $799K Shares 624,046 Est. Cost Unrealized
DRUG BRIGHT MINDS BIOSCIENCES INC 0.4%
Value $710K Shares 10,110 Est. Cost Unrealized
CMPX COMPASS THERAPEUTICS INC 0.4%
Value $605K Shares 276,165 Est. Cost Unrealized
REPL REPLIMUNE GROUP INC 0.3%
Value $447K Shares 40,361 Est. Cost Unrealized
ABUS ARBUTUS BIOPHARMA CORP 0.1%
Value $241K Shares 50,166 Est. Cost Unrealized